Literature DB >> 6476887

Growth hormone levels in psoriasis.

G C Priestley, D J Gawkrodger, J Seth, S M Going, J A Hunter.   

Abstract

Plasma growth-hormone levels in 12 fasting psoriatics were 4.4 +/- 1.4 mU/l (mean +/- SEM), compared to 2.7 +/- 1.7 in 5 patients with eczema and 1.2 +/- 0.3 in 6 normal subjects. The differences in mean values were not statistically significant and were due to exceptionally high levels of growth hormone in five patients with psoriasis and one patient with eczema. In the psoriatic group the exceptional patients were not distinguished by age or the area of involved skin but they tended to be leaner than those with low plasma-growth hormone levels. We conclude that raised plasma growth hormone cannot be the cause of psoriasis but might be a secondary effect of the skin disease in some patients.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6476887     DOI: 10.1007/bf00414010

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  10 in total

1.  Periarticular uptake of 99mtechnetium diphosphonate in psoriatics: correlation with cutaneous activity.

Authors:  T C Namey; L Rosenthall
Journal:  Arthritis Rheum       Date:  1976 May-Jun

2.  Response of blood insulin and growth hormone to glucose infusion in normal, psoriatic and diabetic persons.

Authors:  V K Hopsu-Havu; P E Terho; T P Vanha-Perttula; M K Viljanen
Journal:  Acta Derm Venereol       Date:  1973       Impact factor: 4.437

3.  Serum insulin and growth hormone response to arginine infusion in healthy and psoriatic persons.

Authors:  V K Hopsu-Havu; A Niinikoski; J E Haapalahti; C T Jansén
Journal:  Dermatologica       Date:  1973

4.  Growth hormone levels in psoriasis.

Authors:  R M MacKie; G M Beastall; J A Thomson
Journal:  Arch Dermatol Res       Date:  1983       Impact factor: 3.017

5.  Treatment of psoriasis with bromocriptin.

Authors:  G Weber; M Neidhardt; H Frey; K Galle; A Geiger
Journal:  Arch Dermatol Res       Date:  1981       Impact factor: 3.017

6.  [Correlation of growth hormone and aetiology of psoriasis].

Authors:  G Weber; M Neidhardt; A Schmidt; A Geiger
Journal:  Arch Dermatol Res       Date:  1981       Impact factor: 3.017

7.  Psoriasis and human growth hormone: aetiology and therapy.

Authors:  G Weber; G Klughardt; M Neidhardt
Journal:  Arch Dermatol Res       Date:  1981       Impact factor: 3.017

8.  Treatment of psoriasis with somatostatin.

Authors:  G Weber; G Klughardt; M Neidhardt; K Galle; H Frey; A Geiger
Journal:  Arch Dermatol Res       Date:  1982       Impact factor: 3.017

9.  A radioimmunoassay for human prolactin.

Authors:  P Hwang; H Guyda; H Friesen
Journal:  Proc Natl Acad Sci U S A       Date:  1971-08       Impact factor: 11.205

10.  The activity of polymorphonuclear leukocyte neutral proteinases and their inhibitors in patients with psoriasis treated with a continuous peritoneal dialysis.

Authors:  W Glinski; Z Zarebska; S Jabłonska; J Imiela; J Nosarzewski
Journal:  J Invest Dermatol       Date:  1980-12       Impact factor: 8.551

  10 in total
  6 in total

1.  Increased birth weight in psoriasis--another expression of a "thrifty genotype"?

Authors:  P Propping; C Hohenschutz; V Voigtländer
Journal:  Hum Genet       Date:  1985       Impact factor: 4.132

2.  Increased phosphorylation of two 48 kDa nuclear proteins in fibroblasts derived from psoriatic patients.

Authors:  M Späder; G Unteregger
Journal:  Arch Dermatol Res       Date:  1989       Impact factor: 3.017

Review 3.  The psoriatic epidermal lesion and anagen hair growth may share the same "switch-on" mechanism.

Authors:  R Paus; R E Link
Journal:  Yale J Biol Med       Date:  1988 Sep-Oct

4.  Follicular-Stimulating Hormone, Luteinizing Hormone, and Prolactin Serum Level in Patients with Oral Lichen Planus in Comparison to Healthy Population.

Authors:  Fatemeh Lavaee; Nazila Bazrafkan; Fateme Zarei; Maryam Shahrokhi Sardo
Journal:  Biomed Res Int       Date:  2021-10-26       Impact factor: 3.411

5.  Association of psoriasis severity with serum prolactin, thyroid hormones, and cortisol before and after treatment.

Authors:  Reza M Robati; Parviz Toossi; Mohammad Rahmati-Roodsari; Sara Khalilazar; Ehsan Abolhasani; Nastaran Namazi; Shima Younespour
Journal:  ScientificWorldJournal       Date:  2013-10-28

6.  Serum prolactin levels in psoriasis and its association with disease activity: a case-control study.

Authors:  Mohammad Abid Keen; Iffat Hassan
Journal:  Indian J Dermatol       Date:  2014-11       Impact factor: 1.494

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.